5,N,N-TMT
From Wikipedia, the free encyclopedia
|
5,N,N-TMT
|
|
| Systematic (IUPAC) name | |
| (2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C13H18N2 |
| Mol. mass | 202.30 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was first made in 1958 by E. H. Young. [1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency [2] [3] which would suggest an active dosage for humans in the 20-60mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.
[edit] References
- ^ Young EH, J. Chem. Soc. 3493 (1958)
- ^ Glennon et al, J. Med. Chem. 22:428-432 (1979)
- ^ Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158
|
|||||

